Literature DB >> 29895999

Nonimmune Hydrops Fetalis: Factors Which Predict Outcome.

Manisha Kumar1, Vandana Jha1, Anuradha Singh1.   

Abstract

AIMS AND
OBJECTIVE: To evaluate the cause of NIHF cases referred to a tertiary referral center and to analyze the outcome.
MATERIALS AND METHODS: A total of 130 cases of fetal hydrops registered during eight-year study period were reviewed. Antenatal ultrasound, blood investigations and postnatal fetal examination were done, and outcome was noted.
RESULTS: Out of 130 cases of NIHF, antenatal ultrasound showed the presence of structural malformations in 94/130 (72.3%), cardiac abnormality was the most common (34/130, 26.1%) and cystic hygroma was seen in 15/130 (11.5%). Chromosomal abnormality was observed in 15(11.5%) cases, and Doppler US showed anemia in 4/130 (3.1%) cases only. Live born were 25 (12.9%), and rest all were stillborn or abortion. Later mean gestational age of presentation (p = 0.0001), presence of gastrointestinal malformation (p = 0.0001) and absence of structural malformations (p = 0.0441) were factors significantly associated with live birth; the presence of cystic hygroma (p = 0.0431) or structural heart defect (p = 0.007) was significantly associated with poor outcome.
CONCLUSION: Fetal anemia was not a common cause of NIHF in the study population. The early onset of hydrops and presence of structural malformation carry a graver prognosis; type of structural defect also has bearing on outcome.

Entities:  

Keywords:  Nonimmune hydrops; Prenatal diagnosis; Ultrasound

Year:  2017        PMID: 29895999      PMCID: PMC5972088          DOI: 10.1007/s13224-017-1011-6

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  11 in total

Review 1.  Nonimmune hydrops fetalis part II: does etiology influence mortality?

Authors:  Andrea L Randenberg
Journal:  Neonatal Netw       Date:  2010 Nov-Dec

Review 2.  Etiology of nonimmune hydrops fetalis: a systematic review.

Authors:  Carlo Bellini; Raoul C M Hennekam; Ezio Fulcheri; Mariangela Rutigliani; Guido Morcaldi; Francesco Boccardo; Eugenio Bonioli
Journal:  Am J Med Genet A       Date:  2009-05       Impact factor: 2.802

3.  Etiology of non-immune hydrops fetalis: An update.

Authors:  Carlo Bellini; Gloria Donarini; Dario Paladini; Maria Grazia Calevo; Tommaso Bellini; Luca A Ramenghi; Raoul C Hennekam
Journal:  Am J Med Genet A       Date:  2015-02-25       Impact factor: 2.802

4.  Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis.

Authors:  Shiyo Ota; Jun Sahara; Aki Mabuchi; Ryo Yamamoto; Keisuke Ishii; Nobuaki Mitsuda
Journal:  J Obstet Gynaecol Res       Date:  2015-12-29       Impact factor: 1.730

Review 5.  Diagnosis and treatment of foetal heart failure: foetal echocardiography and foetal hydrops.

Authors:  James C Huhta
Journal:  Cardiol Young       Date:  2015-08       Impact factor: 1.093

Review 6.  Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis.

Authors:  Mary E Norton; Suneet P Chauhan; Jodi S Dashe
Journal:  Am J Obstet Gynecol       Date:  2014-12-31       Impact factor: 8.661

Review 7.  Nonimmune hydrops fetalis part I: etiology and pathophysiology.

Authors:  Andrea L Randenberg
Journal:  Neonatal Netw       Date:  2010 Sep-Oct

8.  Prevalence and molecular characterization of alpha-thalassemia syndromes among Indians.

Authors:  Anita Nadkarni; Supriya Phanasgaonkar; Roshan Colah; Dipika Mohanty; Kanjaksha Ghosh
Journal:  Genet Test       Date:  2008-06

9.  Ultrasonographic severity scoring of non-immune hydrops: a predictor of perinatal mortality.

Authors:  Su Ah Kim; Seung Mi Lee; Joon-Seok Hong; JoonHo Lee; Chan-Wook Park; Byoung Jae Kim; Kyo Hoon Park; Joong Shin Park; Jong Kwan Jun
Journal:  J Perinat Med       Date:  2015-01       Impact factor: 1.901

10.  Clinical characteristics and perinatal outcome of fetal hydrops.

Authors:  Wonkyung Yeom; E Sun Paik; Jung-Joo An; Soo-Young Oh; Suk-Joo Choi; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2015-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.